HELP     Sign In
Search

Relevance to Autism

This gene was originally identified as an ASD candidate gene based on its enrichment in an autism-associated protein interaction module. Sequencing of post-mortem brain tissue from 25 ASD cases resulted in the identification of significant non-synonymous variants in this gene with an expected false-positive rate at 0.1, confirming the involvement of this module with autism; this finding was further validated by exome sequencing of an independent cohort of 505 ASD cases and 491 controls (Li et al., 2014).

Molecular Function

This gene encodes a multi-domain protein that is predominantly expressed in brain and testis. This protein interacts with amyloid beta protein precursor (AbetaPP) and may have a role in normal brain development, and in the pathogenesis of Alzheimer's disease.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Integrated systems analysis reveals a molecular network underlying autism spectrum disorders.
ASD
Support
A recurrent PJA1 variant in trigonocephaly and neurodevelopmental disorders
ASD, DD
Support
Meta-Analyses Support Previous and Novel Autism Candidate Genes: Outcomes of an Unexplored Brazilian Cohort.
ASD
Recent Recommendation
ASD
Recent Recommendation
Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome.
ASD, ADHD, DD, ID

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN673R001 
 missense_variant 
 c.50C>T 
 p.Ala17Val 
 Unknown 
  
 Unknown 
 GEN673R002 
 nonsynonymous_variant 
  
  
 Unknown 
  
 Unknown 
 GEN673R003 
 missense_variant 
 c.2240C>G 
 p.Ser747Cys 
 Unknown 
  
 Unknown 
 GEN673R004 
 copy_number_loss 
  
  
 Familial 
 Paternal 
 Multiplex 
 GEN673R005 
 copy_number_loss 
  
  
 Familial 
 Paternal 
 Simplex 
 GEN673R006 
 copy_number_loss 
  
  
 Familial 
 Paternal 
  
 GEN673R007 
 copy_number_loss 
  
  
 Familial 
 Maternal 
  
 GEN673R008 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN673R009 
 copy_number_loss 
  
  
 Familial 
 Maternal 
  
 GEN673R010 
 copy_number_loss 
  
  
 Familial 
 Paternal 
  
 GEN673R011 
 copy_number_loss 
  
  
 Familial 
  
  
 GEN673R012 
 copy_number_loss 
  
  
 Familial 
  
 Simplex 
 GEN673R013 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN673R014 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN673R015 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN673R016 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN673R017 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN673R018 
 copy_number_loss 
  
  
 Familial 
 Paternal 
  
 GEN673R019 
 copy_number_loss 
  
  
 De novo 
  
  
 GEN673R020 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN673R021 
 missense_variant 
 c.1568G>A 
 p.Arg523Gln 
 De novo 
  
 Simplex 
 GEN673R022a 
 missense_variant 
 c.140T>C 
 p.Ile47Thr 
 De novo 
  
 Simplex 
 GEN673R022b 
 splice_region_variant 
 c.85-6C>T 
 p.? 
 Unknown 
  
 Simplex 
 GEN673R023 
 frameshift_variant 
 AGT>A 
  
 Familial 
 Maternal 
 Multiplex 
 GEN673R024 
 missense_variant 
 c.284C>A 
 p.Pro95His 
 De novo 
  
 Multiplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
12
Duplication
 1
 
12
Deletion-Duplication
 19
 

Model Summary

Anks1b happloinsufficient mice show social deficits, hyperactivity, decrease in anxiety, and sensorimotor dysfunction. Anks1b happloinsufficient mice show sex-specific differences, with a decrease in weight, body length, and brain mass in male mice that was not significant in females. Anks1b happloinsufficient mice show no histological changes in the hippocampus and cerebellum, no change in grooming, no change in homing, negative geotaxis, and acoustic startle tests in pups from P10 to P16. Mutants show no developmental delay. Mutants show no change in frequency, syllable counts and intervals, or syllable repertoires in ultrasonic vocalization.

References

Type
Title
Author, Year
Primary
Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome.
Additional

M_ANKS1B_1_CKO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: A transgenic Nestin-Cre mouse line deletes exon 7 of Anks1B, the first exon of the phosphotyrosine binding domain (PTB) flanked by loxp sites, from the developing central and peripheral nervous system starting at embryonic day 11. Nestin-Cre;Anks1b^wt/wt littermates (Nestin-WT mice) are used as controls.
Allele Type: Conditional knockout
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: Tindi JO, et al, 2015 (Anks1B-floxed); Jackson Laboratories (Nestin-Cre, #003771)

M_ANKS1B_2_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: A transgenic Nestin-Cre mouse line deletes exon 7 of Anks1B, the first exon of the phosphotyrosine binding domain (PTB) flanked by loxp sites, from the developing central and peripheral nervous system starting at embryonic day 11. Nestin-Cre;Anks1b^wt/wt littermates (Nestin-WT mice) are used as controls.
Allele Type: Conditional knockout
Strain of Origin:
Genetic Background: C57BL/6J
ES Cell Line:
Mutant ES Cell Line:
Model Source: Tindi JO, et al, 2015 (Anks1B-floxed); Jackson Laboratories (Nestin-Cre, #003771)

M_ANKS1B_3_CKO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: Olig2-heterozygote mice have one copy of the Anks1b-flox allele (MGI:5779292) in which exon 20 is flanked by loxP sites, and one copy of the Olig2-Cre gene (MGI:3810299) which encodes the transgene with the avian specific retroviral receptor (TVA) followed by an IRES-cre and neo cassette inserted immediately downstream of the Olig2 translation initiation site.
Allele Type: Conditional knockout
Strain of Origin: (C57BL/6NTac x 129S6/SvEvTac)F1; 129
Genetic Background: C57BL/6J
ES Cell Line: iTL BA1; Not specified
Mutant ES Cell Line:
Model Source:

M_ANKS1B_4_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Olig2-knockout mice have two copies of the Anks1b-flox allele (MGI:5779292) in which exon 20 is flanked by loxP sites, and one copy of the Olig2-Cre gene (MGI:3810299) which encodes the transgene with the avian specific retroviral receptor (TVA) followed by an IRES-cre and neo cassette inserted immediately downstream of the Olig2 translation initiation site.
Allele Type: Conditional knockout
Strain of Origin: (C57BL/6NTac x 129S6/SvEvTac)F1; 129
Genetic Background: C57BL/6J
ES Cell Line: iTL BA1; Not specified
Mutant ES Cell Line:
Model Source:

M_ANKS1B_5_CKO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: L7-heterozygote mice have one copy of the Anks1b-flox allele (MGI:5779292) in which exon 20 is flanked by loxP sites, and one copy of the L7-Cre transgene (MGI:2137515) which encodes the Cre recombinase under the direction of the Purkinje cell-specific L7/Pcp2 promoter.
Allele Type: Conditional knockout
Strain of Origin: (C57BL/6NTac x 129S6/SvEvTac)F1; (129X1/SvJ x 129S
Genetic Background: Not specified
ES Cell Line: iTL BA1; R1
Mutant ES Cell Line:
Model Source:

M_ANKS1B_6_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: L7-knockout mice have two copies of the Anks1b-flox allele (MGI:5779292) in which exon 20 is flanked by loxP sites, and one copy of the L7-Cre transgene (MGI:2137515) which encodes the Cre recombinase under the direction of the Purkinje cell-specific L7/Pcp2 promoter.
Allele Type: Conditional knockout
Strain of Origin: (C57BL/6NTac x 129S6/SvEvTac)F1; (129X1/SvJ x 129S
Genetic Background: Not specified
ES Cell Line: iTL BA1; R1
Mutant ES Cell Line:
Model Source:

M_ANKS1B_7_CKO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: CamK2a-knockout mice have two copies of the Anks1b-flox allele (MGI:5779292) in which exon 20 is flanked by loxP sites, and one copy of the CamK2a-Cre transgene (MGI:2177650) which encodes Cre recombinase under the control of the alpha subunit of the calcium/calmodulin-dependent protein kinase II promoter.
Allele Type: Conditional knockout
Strain of Origin: (C57BL/6NTac x 129S6/SvEvTac)F1; Not specified
Genetic Background: Not specified
ES Cell Line: iTL BA1; Not specified
Mutant ES Cell Line:
Model Source:

M_ANKS1B_1_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity: ambulatory activity1
Increased
Description: Mutants show increase in total distance travelled.
Exp Paradigm: NA
 Open field test
 4 months
General locomotor activity1
Increased
Description: Mutants spent more time running.
Exp Paradigm: NA
 Open field test
 4 months
Motor coordination and balance: fine motor skills1
Decreased
Description: Mutants take more time to remove adhesive tape, indicating decrease in fine motor skills.
Exp Paradigm: NA
 Adhesive tape test
 4 months
Number of oligodendrocytes2
Decreased
Description: Nestin-heterozygote mice show fewer Olig2-positive oligodendrocytes in the corpus callosum.
Exp Paradigm: Olig2
 Immunohistochemistry
 Unreported
Cerebellar morphology2
Increased
Description: Nestin-heterozygote mice show significant changes in the cerebellar lobule VI.
Exp Paradigm: Nissl
 Histology
 Unreported
Myelination2
Decreased
Description: Nestin-heterozygote mice show a decrease in immunostaining for myelin basic protein (MBP) in the corpus callosum and cerebellar cortex.
Exp Paradigm: Myelin basic protein
 Immunohistochemistry
 Unreported
Morphology and size of the corpus callosum2
Decreased
Description: Nestin-heterozygous mice show a significant decrease in the volume of the corpus callosum.
Exp Paradigm: T2-weighted MRIs of ex vivo brain tissue from 10 female Anks1b Nestin-Het and 10 female WT controls (age 3 months) reveal
 Magnetic resonance imaging (MRI)
 3 months
Neuronal specification2
Decreased
Description: In Nestin-heterozygote mice, there are significantly fewer mature oligodendrocytes (CC1-positive) derived from newborn cells throughout all time points tested. There is also a significant increase in OPCs and immature oligodendrocytes (PDGFRa- positive) in Nestin-heterozygote mice at 3 weeks and 6 months of age.
Exp Paradigm: CC1, PDGFRa
 Immunohistochemistry
 3 weeks, 2 months, 6 months, 12 months
Cell proliferation: neural precursors2
Decreased
Description: There are significantly fewer newborn cells overall in the corpus callosum of Nestin-heterozygote mice.
Exp Paradigm: corpus callosum
 Pulse-chase analysis
 3 weeks, 2 months, 6 months, 12 months
Myelination2
Decreased
Description: Brain slices stained with Luxol Fast Blue (LFB), a copper phthalocyanine dye that binds to lipoproteins of the myelin sheath, show that both male and female Nestin-heterozygote mice have decreased LFB staining intensity compared to wildtype littermates in the corpus callosum as well as in the cerebellum.
Exp Paradigm: Luxol Fast Blue
 Histology
 Unreported
Hippocampal morphology2
Increased
Description: Nestin-heterozygote mice show significant changes in the CA1/2 region of the hippocampus.
Exp Paradigm: Nissl
 Histology
 Unreported
Neuronal migration2
Decreased
Description: Newborn oligodendrocytes accumulated at lesioned areas in wildtype mice, and then dispersed throughout the corpus callosum. In contrast, there are significantly fewer newborn cells in demyelinated areas in Nestin-heterozygote mice. Moreover, significantly fewer of these cells were of oligodendrocyte lineage, as indicated by co-labeling with Olig2.
Exp Paradigm: after injury in corpus callosum
 Pulse-chase analysis
 6-8 weeks
Brain size1
Decreased
Description: Mutant males but not females show decrease in brain size.
Exp Paradigm: NA
 Measurement of tissue weight
 Adult
Morphology and size of the optic tract2
Decreased
Description: Nestin-heterozygote mice show a significant decrease in the volume of highly myelinated brain structures including the optic tract.
 Magnetic resonance imaging (MRI)
 3 months
Size of cerebral ventricles: lateral ventricle2
Increased
Description: Nestin-heterozygote mice show larger lateral ventricles (LV) compared to wildtype littermates.
Exp Paradigm: Nissl
 Histology
 Unreported
DTI: fractional anisotropy or relative anisotropy in brain regions2
Decreased
Description: In vivo DTI analyses of Nestin-heterozygote mouse brains show a significant decrease in fractional anisotropy of callosal and other tracts.
Exp Paradigm: T2-weighted MRIs of ex vivo brain tissue from 10 female Anks1b Nestin-Het and 10 female WT controls (age 3 months) reveal
 Diffusion tensor imaging
 3 months
Myelination2
Decreased
Description: Quantification revealed a significant increase in g-ratio (signifying decreased myelination) in Nestin-heterozygote mice in the most common axon diameters (0.3â??1.7 microns).
 g-ratio measurement (axon diameters/fiber diameters of myelinated axons)
 Unreported
Morphology and size of the corpus callosum2
Decreased
Description: Nissl staining confirmed that Nestin-heterozygote mice have a thinner corpus callosum throughout the rostrocaudal axis.
Exp Paradigm: Nissl
 Histology
 Unreported
Startle response: acoustic stimulus1
Increased
Description: Mutants show increase in amplitude of peak response.
Exp Paradigm: NA
 Acoustic startle reflex test
 4 months
Sensorimotor gating1
Decreased
Description: Mutants show decrease in percent prepulse inhibition.
Exp Paradigm: NA
 Prepulse inhibition
 4 months
Social approach1
Decreased
Description: Mutants spent less time interacting with a social stimulus.
Exp Paradigm: NA
 Three-chamber social approach test
 4 months
Size/growth1
Decreased
Description: Mutant males but not females show decrease in body weight.
Exp Paradigm: NA
 Body weight measurement
 Adult
Size/growth1
Decreased
Description: Mutant males but not females show decrease in body length.
Exp Paradigm: NA
 Body length measurement
 Adult
Anxiety1
Decreased
Description: Mutants spent more time in the open arm.
Exp Paradigm: NA
 Elevated plus maze test
 4 months
Anxiety1
Decreased
Description: Mutants show increase in number of visits, time, and percentage of total track in the center square.
Exp Paradigm: NA
 Open field test
 4 months
Object recognition memory1
Decreased
Description: Mutants show no preference for object at novel location.
Exp Paradigm: NA
 Object-place recognition test
 4 months
Targeted expression1
Decreased
Description: Mutants show decreased aida-1b, c and d protein levels in the brain.
Exp Paradigm: NA
 Western blot
 Not reported
Targeted expression1
Decreased
Description: Mutants show decreased anks1b transcript levels including exons 4, 13 an 20, in the brain.
Exp Paradigm: NA
 Quantitative pcr (qrt-pcr)
 Not reported
Ultrasonic vocalization: isolation induced1
 No change
 Monitoring ultrasonic vocalizations
 P10-p16
Mortality/lethality1
 No change
 General observations
 Adult
Depression1
 No change
 Forced swim test
 4 months
Motor coordination and balance1
 No change
 Balance beam test
 4 months
Negative geotaxis1
 No change
 Negative geotaxis test
 P10-p16
Brain morphology2
 No change
 Histology
 Unreported
Brain size2
 No change
 Magnetic resonance imaging (MRI)
 3 months
Cell proliferation: neural precursors2
 No change
 BrdU incorporation
 Unreported
Cerebellar morphology1
 No change
 Histology
 4 months
Hippocampal morphology1
 No change
 Histology
 4 months
Self grooming: perseveration1
 No change
 Open field test
 4 months
Rearing behavior1
 No change
 Open field test
 4 months
Social scent marking or recognition1
 No change
 Homing test
 P10-p16
 Not Reported: Circadian sleep/wake cycle, Immune response, Maternal behavior, Neurophysiology, Physiological parameters, Seizure

M_ANKS1B_2_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Mortality/lethality: embryonic1
Increased
Description: Mutants do not survive beyond p0.
Exp Paradigm: NA
 General observations
 P0
 Not Reported: Circadian sleep/wake cycle, Communications, Emotion, Immune response, Learning & memory, Maternal behavior, Molecular profile, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_ANKS1B_3_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Number of oligodendrocytes1
Decreased
Description: Olig2-heterozygote mice exhibit fewer oligodendrocytes in the corpus callosum.
Exp Paradigm: GFP
 Immunohistochemistry
 Unreported
Myelination1
Decreased
Description: Western blots show reduced myelin basic protein in Olig2-heterozygote mice.
Exp Paradigm: Myelin basic protein
 Western blot
 Unreported
Myelination1
Decreased
Description: TEM imaging shows a decrease in myelination of callosal axons of Olig2-heterozygote mice, as measured using g-ratios.
 g-ratio measurement (axon diameters/fiber diameters of myelinated axons)
 Unreported
Number of oligodendrocytes1
Decreased
Description: Western blots confirm decreased oligodendrocyte makers Olig2 and Sox10 overall in Olig2-heterozygote mice.
Exp Paradigm: Olig2, Sox10
 Western blot
 Unreported
Startle response: acoustic stimulus1
Increased
Description: Olig2-heterozygote mice show significantly increased sensory hyperreactivity as demonstrated by increased startle to sounds at 100 dB and 110 dB, but not at 90 dB compared to wildtype littermates.
 Acoustic startle reflex test
 3-4 months
Social approach1
Decreased
Description: Olig2-heterozygote mice show decreased social preference for a conspecific mouse over an inanimate object.
 Three-chamber social approach test
 3-4 months
Size/growth1
Decreased
Description: Olig2-heterozygote mice show a decreased body weight.
 Body weight measurement
 Unreported
Size/growth1
Decreased
Description: Olig2-heterozygote female mice show a significant decrease in body length, while male mice do not show a significant change.
 Body length measurement
 Unreported
Anxiety1
Abnormal
Description: Olig2-heterozygote mice spent more time in the open arms of the elevated plus maze (decreased anxiety) but covered less distance in the open arms (increased anxiety).
 Elevated plus maze test
 3-4 months
Mortality/lethality1
 No change
 Genotypic ratio of progeny from heterozygous parents
 Unreported
Anxiety1
 No change
 Open field test
 3-4 months
Depression1
 No change
 Forced swim test
 3-4 months
Object recognition memory1
 No change
 Object-place recognition test
 3-4 months
General locomotor activity1
 No change
 Open field test
 3-4 months
General locomotor activity: ambulatory activity1
 No change
 Open field test
 3-4 months
Rearing behavior1
 No change
 Open field test
 3-4 months
Self grooming1
 No change
 Open field test
 3-4 months
Sensorimotor gating1
 No change
 Prepulse inhibition
 3-4 months
 Not Reported:

M_ANKS1B_4_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Number of oligodendrocytes1
Decreased
Description: Olig2-knockout mice exhibit fewer oligodendrocytes in the corpus callosum.
Exp Paradigm: GFP
 Immunohistochemistry
 Unreported
Startle response: acoustic stimulus1
Increased
Description: Olig2-knockout mice show significantly increased sensory hyperreactivity as demonstrated by increased startle to sounds at 100 dB and 110 dB, but not at 90 dB compared to wildtype littermates.
 Acoustic startle reflex test
 3-4 months
Social approach1
Decreased
Description: Olig2-knockout mice show decreased social preference for a conspecific mouse over an inanimate object.
 Three-chamber social approach test
 3-4 months
Size/growth1
Decreased
Description: Olig2-knockout male mice show a significant decrease in body length while female mice do not show a significant change.
 Body length measurement
 Unreported
Mortality/lethality: incomplete penetrance1
Increased
Description: Oligodendrocyte-specific Anks1b homozygous (Olig2-knockout) mice are viable, although knockout mice were born at rates below expected Mendelian ratios and were smaller than their wildtype counterparts.
 Genotypic ratio of progeny from heterozygous parents
 Unreported
Size/growth1
Decreased
Description: Olig2-knockout mice show a decreased body weight.
 Body weight measurement
 Unreported
Anxiety1
Abnormal
Description: Olig2-knockout mice spent more time in the open arms of the elevated plus maze (decreased anxiety) but covered less distance in the open arms (increased anxiety).
 Elevated plus maze test
 3-4 months
Anxiety1
 No change
 Open field test
 3-4 months
Depression1
 No change
 Forced swim test
 3-4 months
Object recognition memory1
 No change
 Object-place recognition test
 3-4 months
General locomotor activity1
 No change
 Open field test
 3-4 months
General locomotor activity: ambulatory activity1
 No change
 Open field test
 3-4 months
Rearing behavior1
 No change
 Open field test
 3-4 months
Self grooming1
 No change
 Open field test
 3-4 months
Sensorimotor gating1
 No change
 Prepulse inhibition
 3-4 months
 Not Reported:

M_ANKS1B_5_CKO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Social approach1
 No change
 Three-chamber social approach test
 3-4 months
 Not Reported:

M_ANKS1B_6_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Social approach1
 No change
 Three-chamber social approach test
 3-4 months
 Not Reported:

M_ANKS1B_7_CKO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Size/growth1
 No change
 Body length measurement
 Unreported
Size/growth1
 No change
 Body weight measurement
 Unreported
Brain morphology1
 No change
 Histology
 Unreported
Brain size1
 No change
 Histology
 Unreported
Brain size1
 No change
 Measurement of tissue weight
 Unreported
Cerebellar morphology1
 No change
 Histology
 Unreported
Hippocampal morphology1
 No change
 Histology
 Unreported
Morphology and size of the corpus callosum1
 No change
 Histology
 Unreported
Myelination1
 No change
 Western blot
 Unreported
Size of cerebral ventricles: lateral ventricle1
 No change
 Histology
 Unreported
Social approach1
 No change
 Three-chamber social approach test
 3-4 months
 Not Reported:

 

No Interactions Available
HELP
Copyright © 2017 MindSpec, Inc.